Your mission
This position will be part of R&D department within Adragos Athens, member of Adragos Pharma; a globally operating pharmaceutical Contract Development and Manufacturing Organisation (CDMO). The R&D Analytical Scientist will accommodate a wide range of R&D analytical laboratory activities pertaining to the development of analytical methods suitable for final product quality control purposes, as well as the efficient execution of a variety of analytical studies supporting drug product development activities. The R&D Analytical Scientist will be expected to operate within a competent team of analytical scientists (chemists and pharmacists) and will report to the R&D Senior Manager.
Role Responsibilities
- Set up and execute science-driven and phase appropriate analytical strategies to support product development projects.
- Actively participate in analytical method development activities for the final products.
- Positively liaise with the rest of the team in order to ensure the effective operation of the R&D department Analytical laboratory.
- Carry out the execution of Formulation stability study protocols and the compilation of reports containing the scientific outcome of the analytical studies.
About us
Adragos Pharma is a reliable Contract Development and Manufacturing Organization (CDMO) headquartered in Munich, Germany. We provide comprehensive development and manufacturing services for drug products, including sterile and non-sterile liquids, solids, and semi-solids. Our expertise also covers biologicals, orphan drugs, clinical trials, fill-and-finish, and lyophilization, offering end-to-end solutions from product development to commercial supply.
With production sites in Germany, France, Greece, Norway, Japan, and Switzerland, we ensure high-quality manufacturing across all stages of the drug development process.
Founded in 2020, Adragos Pharma has rapidly grown through an ambitious buy & build strategy, supported by FSN Capital. With a team of over 900 professionals, we are expanding our operations across Europe, North America, and Japan to become a global leader in the CDMO sector.
As a key player in the pharmaceutical industry, CDMOs like Adragos produce 25% of all drugs globally, ensuring access to essential medications. With increasing healthcare demands, we continue to innovate and set new standards in drug manufacturing.
You want to be part of our dynamic growth? Then apply now!
